HIV vaccine based on targeting maximized Gag and Nef to dendritic cells

Details for Australian Patent Application No. 2012202953 (hide)

Owner Baylor Research Institute

Inventors Banchereau, Jacques F.; Zurawski, Gerard; Flamar, Anne-laure; Cobb, Amanda; Mead, Holly; Montes, Monica

Agent Pizzeys

Pub. Number AU-A-2012202953

Parent 2009270771

Filing date 21 May 2012

Wipo publication date 14 June 2012

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

7 June 2012 Complete Application Filed

14 June 2012 Application Open to Public Inspection

  Published as AU-A-2012202953

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202954-Game account access device

2012202952-Devices, Systems And Methods To Treat Heart Failure